MS
MGNX icon

Maven Securities’s MacroGenics MGNX Stock Holding History

Maven Securities’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,000
Closed -$440K – 1211
2021
Q1 		$440K Buy
+14,000
New +$340K 0.02% 711
2018
Q2 		– Sell
-41,955
Closed -$1.06M – 86
2018
Q1 		$1.06M Buy
+41,955
New +$1.02M 0.56% 29

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Maven Securities's MGNX Position: Q2 2021 in Review

Maven Securities sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 14,000 shares — an estimated $440K sold.

Maven Securities first reported a position in MGNX in Q1 2018 and held it in 2 quarters. The position peaked at $1.06M in Q1 2018. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Maven Securities reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 14,000 MacroGenics shares in Q2 2021, an estimated $440K.
  • Maven Securities first reported a position in MacroGenics in Q1 2018 and held it in 2 quarters.
  • Maven Securities's MacroGenics position peaked at $1.06M in Q1 2018.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.